2009
DOI: 10.3945/ajcn.2008.26590
|View full text |Cite
|
Sign up to set email alerts
|

Docosahexaenoic acid supplementation and time at achievement of gross motor milestones in healthy infants: a randomized, prospective, double-blind, placebo-controlled trial

Abstract: Despite the 1-wk advance in sitting without support associated with DHA supplementation, no demonstrable persistent effects of DHA supplementation on later motor development milestones were found. Thus, the long-term clinical significance of the 1-wk change in sitting without support, if any, remains unknown. This trial is registered at (clinicaltrials.gov) as NCT00610922.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
27
0
1

Year Published

2009
2009
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 37 publications
(30 citation statements)
references
References 33 publications
1
27
0
1
Order By: Relevance
“…These data may indicate that effects at younger ages may be too subtle to detect with smaller sample sizes. Supplementation with LC-PUFA in term infants shortened the time to achieving a milestone of motor development (sitting without support) [88]. …”
Section: Resultsmentioning
confidence: 99%
“…These data may indicate that effects at younger ages may be too subtle to detect with smaller sample sizes. Supplementation with LC-PUFA in term infants shortened the time to achieving a milestone of motor development (sitting without support) [88]. …”
Section: Resultsmentioning
confidence: 99%
“…Section 5.1.2.2 reports indications on the levels of preformed DHA in the diet of infants. While 20 mg per day seem to represent the lowest limit of intake in the first six months through human milk (Marangoni et al, 2000) and may partly affect the timing of developmental milestones in the first 12 months (Agostoni et al, 2009), 50 to 100 mg per day have been found effective for the visual function during the subsequent complementary feeding period (Birch et al, 2007;EFSA 2009). …”
Section: Nervous System Functionmentioning
confidence: 99%
“…Results from trials in formula fed infants are more divergent, and could be partly related to un-investigated covariates such as infants" DHA status at birth and the individual genetic background (Simmer et al, 2008). DHA supplementation through the complementary feeding period seems still effective in improving the neuro-functional and visual performance (Birch et al, 2007;Agostoni et al, 2009). Section 5.1.2.2 reports indications on the levels of preformed DHA in the diet of infants.…”
Section: Nervous System Functionmentioning
confidence: 99%
“…Different dietary backgrounds and age periods have been examined. Recent studies on LC-PUFA-supplemented infants over relatively long age periods point to a strong decrease in LC-PUFA synthesis with age (Carnielli et al, 2007;Agostoni et al, 2009), whereas the DINO study suggests an effective n-3 LC-PUFA synthesis when dietary intake is low but n-6/n-3 PUFA ratio in complementary feeding is favorable (Schwartz et al, 2009). …”
Section: Discussionmentioning
confidence: 99%
“…Consumption of meat increased AA concentration in the blood of formula-fed but not of breastfed infants (Luukkainen et al, 1996), whereas consumption of egg yolk increased the DHA concentration (Makrides et al, 2002;Hoffman et al, 2004). LC-PUFA status was significantly higher when LC-PUFAs were supplemented than without supplementation (Carnielli et al, 2007), and resulted in earlier sitting without help at the end of the first year of life (Agostoni et al, 2009). In addition.…”
Section: Discussionmentioning
confidence: 99%